Biote (BTMD) Other Accumulated Expenses (2021 - 2026)

Biote has reported Other Accumulated Expenses for 6 years, with the latest figure at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses changed 0.3% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (changed 0.3% YoY), and the FY2025 full-year result was $1.8 million, up 18.21% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $2.3 million, up from $1.8 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $4.2 million in Q3 2023, with the low at $424000.0 in Q1 2023.
• Average Other Accumulated Expenses over 5 years is $1.8 million, with a median of $1.8 million recorded in 2023.
• Peak annual rise in Other Accumulated Expenses reached 273.35% in 2024, while the deepest fall reached 45.89% in 2024.
• Tracing BTMD's Other Accumulated Expenses over 5 years: stood at $649000.0 in 2022, then jumped by 185.21% to $1.9 million in 2023, then slipped by 18.42% to $1.5 million in 2024, then rose by 18.21% to $1.8 million in 2025, then advanced by 29.75% to $2.3 million in 2026.
• The last three Other Accumulated Expenses figures came in at $2.3 million (Q1 2026), $1.8 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.

Peer Comparison